Rigel Pharmaceuticals
RIGL
#7137
Rank
โ‚ฌ0.41 B
Marketcap
22,72ย โ‚ฌ
Share price
-2.44%
Change (1 day)
24.21%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): โ‚ฌ0.10 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.28 Billion. In 2024 the company made an earning of โ‚ฌ23 Million, an increase over its 2023 earnings that were of -โ‚ฌ15.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.10 B362.8%
2024 โ‚ฌ23 M-244.27%
2023 -โ‚ฌ15.95 Million-66.79%
2022 -โ‚ฌ48.03 Million340.73%
2021 -โ‚ฌ10.9 Million-56.15%
2020 -โ‚ฌ24.86 Million-57.34%
2019 -โ‚ฌ58.27 Million-7.66%
2018 -โ‚ฌ63.1 Million-9.47%
2017 -โ‚ฌ69.7 Million24.46%
2016 -โ‚ฌ56.01 Million23.63%
2015 -โ‚ฌ45.3 Million-43.29%
2014 -โ‚ฌ79.88 Million2.5%
2013 -โ‚ฌ77.94 Million
2010 โ‚ฌ33.14 M-133.97%
2009 -โ‚ฌ97.56 Million-18.49%
2008 -โ‚ฌ0.12 Billion71.91%
2007 -โ‚ฌ69.62 Million84.74%
2006 -โ‚ฌ37.69 Million-10.17%
2005 -โ‚ฌ41.96 Million-15.73%
2004 -โ‚ฌ49.79 Million39.29%
2003 -โ‚ฌ35.74 Million10.3%
2002 -โ‚ฌ32.41 Million48.3%
2001 -โ‚ฌ21.86 Million-2.13%
2000 -โ‚ฌ22.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.21 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.45 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚ฌ95.45 Million-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-โ‚ฌ0.12 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA